Eva Nordström
Chief Operating Officer presso ONCOPEPTIDES AB
Patrimonio netto: 73 070 $ in data 31/03/2024
Profilo
Eva Nordström is currently the Chief Operating Officer & Deputy Managing Director at Oncopeptides AB.
She is also a Director at Utilica AB and Oxcia AB.
Previously, she held positions as a Director & Vice President at AstraZeneca AB, Vice President & Director-Global Product at Pharmacia AB, and Vice President & Director-Global Product at AstraZeneca Pharmaceuticals LP.
Ms. Nordström holds an MBA from Stockholm School of Economics and a graduate degree from the University of Uppsala.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ONCOPEPTIDES AB
0.13% | 29/08/2023 | 120 200 ( 0.13% ) | 73 070 $ | 31/03/2024 |
Posizioni attive di Eva Nordström
Società | Posizione | Inizio |
---|---|---|
ONCOPEPTIDES AB | Chief Operating Officer | 01/01/2020 |
Oxcia AB | Director/Board Member | - |
Utilica AB | Director/Board Member | - |
Precedenti posizioni note di Eva Nordström
Società | Posizione | Fine |
---|---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | - |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Director/Board Member | - |
Pharmacia AB /Hillerod Unit/
Pharmacia AB /Hillerod Unit/ Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pharmacia AB /Hillerod Unit/ is a pharmaceutical company based in Hillerod, Sweden. Pharmacia AB /Hillerod Unit was acquired by Pharmacia AB /Hillerod UnitManagement/ on January 10, 2001. | Corporate Officer/Principal | - |
Formazione di Eva Nordström
Stockholm School of Economics | Masters Business Admin |
University of Uppsala | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ONCOPEPTIDES AB | Health Technology |
Aziende private | 5 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Pharmacia AB /Hillerod Unit/
Pharmacia AB /Hillerod Unit/ Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pharmacia AB /Hillerod Unit/ is a pharmaceutical company based in Hillerod, Sweden. Pharmacia AB /Hillerod Unit was acquired by Pharmacia AB /Hillerod UnitManagement/ on January 10, 2001. | Health Technology |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Utilica AB | |
Oxcia AB |
- Borsa valori
- Insiders
- Eva Nordström